Drug Name:
DALIRESP Rx
Generic Name and Formulations:
Roflumilast 250mcg, 500mcg; tabs.
Company:
AstraZeneca Pharmaceuticals
Therapeutic Use:
Indications for DALIRESP:
To reduce risk of COPD exacerbations in severe COPD patients with chronic bronchitis and a history of exacerbations.
Limitations Of use:
Not for the relief of acute bronchospasm. Daliresp 250mcg is a starting dose only and is not the effective dose.
Adult:
Maintenance: 500mcg once daily. Initiating 250mcg once daily for 4 weeks, then increasing to 500mcg once daily thereafter may reduce the rate of discontinuation in some patients.
Children:
Not established.
Contraindications:
Moderate-to-severe liver impairment (Child-Pugh B or C).
Warnings/Precautions:
History of depression. Suicidal ideation. Monitor for new or worsening insomnia, anxiety, depression, suicidal thoughts, other mood changes; reevaluate if occur. Mild liver impairment (Child-Pugh A). Monitor weight regularly; consider discontinuing if unexplained or significant weight loss occurs. Pregnancy. Labor & delivery, nursing mothers: not recommended.
Interactions:
Concomitant strong CYP450 inducers (eg, rifampicin, phenobarbital, carbamazepine, phenytoin): not recommended. Potentiated by CYP3A4 and CYP1A2 inhibitors (eg, erythromycin, ketoconazole, fluvoxamine, enoxacin, cimetidine), and by oral contraceptives containing gestodene + ethinyl estradiol (possible increased adverse effects).
Pharmacological Class:
Selective phosphodiesterase 4 (PDE4) inhibitor.
Adverse Reactions:
Diarrhea, weight loss, nausea, headache, back pain, influenza, dizziness, decreased appetite; psychiatric effects (eg, insomnia, anxiety, depression).
How Supplied:
Tabs 250mcg—28; 500mcg—30, 90
Endocrinology Advisor Articles
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Nivolumab Associated With Thyroiditis in Patients With Cancer
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Gender-Related Association Between Physical Activity, Psychological Status in T2D
- Adverse Neurodevelopmental and Mental Health Outcomes in PCOS
- HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
- Choroidal Thickness Changes in Patients With Untreated Diabetes
- Pre-Pregnancy Fitness Lowers Gestational Diabetes Risk